Request Clinical Starter Kits for Your Patients Today! Request Now

 Resveratrol STUDIES

Resveratrol improves endothelial function in patients with kidney disease and diabetes, study shows

Highlights Randomized, double-blind, placebo-controlled, cross-over trial involving 21 older adults with stage 3 CKD and diabetes Supplementation consist of ResVida 99% pure, all-trans resveratrol supplementation (200 mg/day, twice daily) for 6 weeks (treatment and matching...
on February 07, 2024

ResVida® resveratrol is readily bioavailable and exerts positive effects on endothelial function, study shows

Highlights Randomized, double-blind, controlled, cross-over with 20 adults with hypertension Supplementation consisted of single doses of resVida® (30, 90 and 270 mg) All amounts of resVida® significantly improve endothelial function...
on February 25, 2020

Resveratrol supplementation reduces key inflammatory biomarkers, meta-analysis shows

Highlights Meta-analysis of 17 randomized, controlled trials (736 participants) Resveratrol supplementation significantly reduces TNF-alpha and C-reactive protein Median dosage is 300 mg/day for 2 months   Summary This meta-analysis was performed...
on February 25, 2020

Resveratrol significantly improves glycemic control in people with diabetes, meta-analysis shows

Highlights Meta-analysis with 11 randomized, controlled clinical trials comprising 388 subjects In people with diabetes, resveratrol significantly improves glucose control and insulin sensitivity. Median intake is 100 mg/day for 12...
on February 25, 2020

Resveratrol improves disease activity and quality of life in people with ulcerative colitis, study shows

Highlights Randomized, double-blind, placebo-controlled trial with 56 adults with mild-to-moderate ulcerative colitis Supplementation consists of trans-resveratrol (500 mg/day) for 6 weeks Resveratrol significantly increases body’s antioxidant status, reduces disease activity and improves...
on February 25, 2020